Citation Tools
Late-breaking abstracts
Clinical trials in-progress
798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update